Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474704 · ClinicalTrials.gov registry record · NA
Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT04474704 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 53 participants.
The verdict
NCT04474704, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This is a single site pilot randomized, controlled, trial randomizing patients with PE with severe features to one of 2 groups: * 24 hours of postpartum magnesium sulfate (current arbitrary standard of care) * Using the Cheetah® device to aid in an individualized duration of magnesium sulfate.
Interventions
- OTHER Standard of care
- DEVICE Cheetah® non-invasive cardiac monitoring system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-02-22 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474704
The ClinicalTrials.gov registry entry for NCT04474704 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of care is the first listed.
NCT04474704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474704 about?
NCT04474704 is a clinical study titled "Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia". This is a single site pilot randomized, controlled, trial randomizing patients with PE with severe features to one of 2 groups: * 24 hours of postpartum magnesium sulfate (current arbitrary standard of care) * Using the Cheetah® device to aid in an individualized duration of magnesium sulfate.
What is the current status of trial NCT04474704?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-02-22. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04474704?
The interventions under investigation include: Standard of care (OTHER), Cheetah® non-invasive cardiac monitoring system (DEVICE).
Who is sponsoring clinical trial NCT04474704?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.